Back
HFA Premium Access

The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction

Session: Rapid Fire 2 - Biomarker: present and future
Topic: Biomarkers
Speaker: Mr M. Henkens (Maastricht, NL)
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speaker

Mr Michiel Henkens

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
0 follower

10 more presentations in this session

Role of neprilysin in myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Speaker: Doctor N. Pavo (Vienna, AT)

Access
Abstract
Like
Thumbnail

The value of tubular maximum phosphate reabsorption capacity, a functional proximal tubular parameter in heart failure

Speaker: Ms L. Emmens (Groningen, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients

Speaker: Doctor R. Nielsen (Aarhus, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Improvement of existing strategies to prevent heart failure after myocardial infarction: a potential role for thrombopoietin

Speaker: Associate Professor L. Malinova (Saratov, RU)

Access
Abstract
Slides
Video
Like
Thumbnail

Plasma Tenascin-C: a novel prognostic biomarker in heart failure with preserved ejection fraction

Speaker: Doctor P. Kanagala (Liverpool, GB)

Access
Abstract
Like
Thumbnail

Access the full session

Rapid Fire 2 - Biomarker: present and future

Speakers: Mr M. Henkens, Doctor N. Pavo, Ms L. Emmens, Doctor R. Nielsen, Associate Professor L. Malinova...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources